Adjusted Relative Risks and Risk Differences Comparing the Impact of Vancomycin to Metronidazole on the Risk of Vancomycin-Resistant Enterococci
| Outcome . | Relative Riska . | 95% CIa . | Risk Differencea (%) . | 95% CIa . |
|---|---|---|---|---|
| VRE clinical culture at 3 months | 0.96 | (.77 to 1.20) | −0.11 | (−.68 to 0.47) |
| VRE bloodstream infection at 3 months | 0.56 | (.3 to 1.05) | −0.22 | (−.45 to 0.00) |
| VRE from any source at 3 months | 0.98 | (.79 to 1.21) | −0.07 | (−.69 to 0.55) |
| VRE in clinical culture at 6 months | 1.05 | (.85 to 1.28) | 0.14 | (−.5 to 0.78) |
| Outcome . | Relative Riska . | 95% CIa . | Risk Differencea (%) . | 95% CIa . |
|---|---|---|---|---|
| VRE clinical culture at 3 months | 0.96 | (.77 to 1.20) | −0.11 | (−.68 to 0.47) |
| VRE bloodstream infection at 3 months | 0.56 | (.3 to 1.05) | −0.22 | (−.45 to 0.00) |
| VRE from any source at 3 months | 0.98 | (.79 to 1.21) | −0.07 | (−.69 to 0.55) |
| VRE in clinical culture at 6 months | 1.05 | (.85 to 1.28) | 0.14 | (−.5 to 0.78) |
Abbreviations: CI, confidence interval; VRE, vancomycin-resistant Enterococci.
aAverage across 50 imputed and propensity score matched datasets.
Adjusted Relative Risks and Risk Differences Comparing the Impact of Vancomycin to Metronidazole on the Risk of Vancomycin-Resistant Enterococci
| Outcome . | Relative Riska . | 95% CIa . | Risk Differencea (%) . | 95% CIa . |
|---|---|---|---|---|
| VRE clinical culture at 3 months | 0.96 | (.77 to 1.20) | −0.11 | (−.68 to 0.47) |
| VRE bloodstream infection at 3 months | 0.56 | (.3 to 1.05) | −0.22 | (−.45 to 0.00) |
| VRE from any source at 3 months | 0.98 | (.79 to 1.21) | −0.07 | (−.69 to 0.55) |
| VRE in clinical culture at 6 months | 1.05 | (.85 to 1.28) | 0.14 | (−.5 to 0.78) |
| Outcome . | Relative Riska . | 95% CIa . | Risk Differencea (%) . | 95% CIa . |
|---|---|---|---|---|
| VRE clinical culture at 3 months | 0.96 | (.77 to 1.20) | −0.11 | (−.68 to 0.47) |
| VRE bloodstream infection at 3 months | 0.56 | (.3 to 1.05) | −0.22 | (−.45 to 0.00) |
| VRE from any source at 3 months | 0.98 | (.79 to 1.21) | −0.07 | (−.69 to 0.55) |
| VRE in clinical culture at 6 months | 1.05 | (.85 to 1.28) | 0.14 | (−.5 to 0.78) |
Abbreviations: CI, confidence interval; VRE, vancomycin-resistant Enterococci.
aAverage across 50 imputed and propensity score matched datasets.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
